A researcher wants to compare transcript abundance for one gene between treated and control cells. Which method is most suitable?
A Karyotyping
B Western blot without an antibody
C Agarose separation of intact chromosomes only
D RT-qPCR with appropriate normalization
Answer: D. RT-qPCR with appropriate normalization. RT-qPCR converts RNA to cDNA and quantifies target abundance relative to controls.
In RNA sequencing, the main molecules analyzed to estimate gene expression are
A RNA-derived sequencing reads
B cell-wall polysaccharides
C ribosome shapes
D unreplicated chromosomes only
Answer: A. RNA-derived sequencing reads. RNA-seq sequences RNA-derived libraries to profile transcripts.
A Northern blot is used to detect a selected
A protein phosphorylation site
B RNA transcript
C lipid species
D chromosome number
Answer: B. RNA transcript. Northern blotting detects specific RNA molecules using a complementary probe.
A luciferase reporter placed under a promoter is used mainly to estimate
A the exact amino-acid sequence of every cell protein
B DNA replication rate
C the promoter’s activity in the tested conditions
D the number of chromosomes in the sample
Answer: C. the promoter’s activity in the tested conditions. Reporter output provides an indirect readout of regulatory activity controlling the reporter gene.
A qPCR experiment reports a target gene’s Ct relative to a validated reference gene. Why normalize?
A To remove the target gene from the sample
B To convert RNA directly into protein
C To make every sample have identical DNA sequence
D To account for differences in input material and technical variation
Answer: D. To account for differences in input material and technical variation. Normalization to stable reference genes helps compare expression across samples with different input or processing variation.
A promoter deletion lowers reporter signal in a cell line. The strongest inference is that the deleted region
A contains sequence needed for full promoter activity in that assay
B is a translated exon
C codes for luciferase protein
D controls chromosome number
Answer: A. contains sequence needed for full promoter activity in that assay. Reduced reporter output suggests the deleted region contributes to transcriptional activity in that experimental context.
Cells show unchanged mRNA abundance but markedly lower protein abundance. Which explanation fits best?
A Transcription must have doubled
B Translation or protein stability may have changed
C The gene has no promoter
D RNA polymerase has become a ribosome
Answer: B. Translation or protein stability may have changed. Protein output can fall because translation is repressed or protein degradation increases.
To determine where a transcript is located within a tissue section, a researcher can use
A a standard blood glucose test
B DNA ligase alone
C in situ hybridization with a sequence-specific probe
D a spectrophotometer for total protein
Answer: C. in situ hybridization with a sequence-specific probe. In situ hybridization visualizes specific RNA transcripts in cells or tissues.
A DNA microarray measures expression by detecting hybridization of labeled cDNA to
A ribosomes attached to membranes
B proteins bound to antibodies only
C cellulose fibers
D gene-specific probes on the array
Answer: D. gene-specific probes on the array. Microarrays compare labeled cDNA binding to probe sequences representing genes.
A ChIP assay is most directly used to test whether a transcription factor
A is associated with a particular DNA region in cells
B is translated from a selected mRNA
C degrades a target protein
D changes the genetic code
Answer: A. is associated with a particular DNA region in cells. Chromatin immunoprecipitation enriches DNA associated with a target protein and can identify binding sites.
CRISPR interference using a DNA-targeted dCas9 repressor can reduce expression by
A editing every RNA codon
B blocking or repressing transcription without cutting the target DNA
C adding a poly-A tail to DNA
D increasing ribosome number
Answer: B. blocking or repressing transcription without cutting the target DNA. CRISPRi uses catalytically inactive Cas9 fused to a repressor to inhibit transcription at a targeted locus.
A sample has twice the normalized target transcript abundance of the control. This is best described as
A a twofold decrease in chromosome number
B proof that protein activity doubled
C a twofold increase in measured expression
D proof that the promoter sequence changed
Answer: C. a twofold increase in measured expression. A twofold RNA abundance change supports increased transcript level, but does not alone establish protein activity.
If a gene’s RNA is abundant only after a stress treatment, the data support
A permanent mutation of every copy of the gene
B translation occurring without RNA
C loss of all housekeeping genes
D stress-associated induction of its transcript
Answer: D. stress-associated induction of its transcript. Higher transcript abundance after treatment is evidence of an expression response under those conditions.
A promoter reporter signal is high in one cell type but low in another. A likely cause is
A different transcription-factor availability between the cell types
B a different genetic code in each cell type
C ribosomes binding the promoter DNA
D the reporter turning into RNA polymerase
Answer: A. different transcription-factor availability between the cell types. Cell types can differ in regulatory proteins that act on the promoter.
Which design best tests whether a candidate enhancer affects a gene?
A Measure only total lipid content
B Compare reporter expression with and without the enhancer in the same assay context
C Remove all ribosomes and inspect DNA
D Compare unrelated genes in different species only
Answer: B. Compare reporter expression with and without the enhancer in the same assay context. A controlled reporter comparison can test the enhancer’s effect on expression in that context.
A qPCR assay for gene expression should generally include a reverse-transcription step because the starting target is
A protein
B lipid
C RNA
D cellulose
Answer: C. RNA. Reverse transcriptase converts RNA to cDNA before PCR amplification.
Which method best measures the abundance of a specific protein rather than its mRNA?
A RT-qPCR
B RNA-seq
C Northern blotting
D Western blotting with a suitable antibody
Answer: D. Western blotting with a suitable antibody. Western blotting detects proteins; RNA-based methods assess transcripts.
A decrease in mature mRNA with unchanged pre-mRNA may point to altered
A RNA processing or stability
B promoter DNA sequence only
C DNA replication initiation
D chromosome segregation
Answer: A. RNA processing or stability. If pre-mRNA remains stable while mature mRNA falls, processing or transcript decay is a plausible control point.
A researcher compares gene-expression profiles from two conditions using RNA-seq. Why are normalization methods needed?
A RNA molecules cannot be sequenced
B Sequencing depth and library composition differ among samples
C All genes have identical transcript lengths
D Normalization removes biological variation
Answer: B. Sequencing depth and library composition differ among samples. Normalization addresses technical differences such as sequencing depth and composition when comparing samples.
A control sample treated with a non-targeting siRNA helps reveal whether a target siRNA’s effect is
A caused by DNA replication
B due to a change in chromosome count
C specific to the intended knockdown rather than a general transfection effect
D independent of all experimental conditions
Answer: C. specific to the intended knockdown rather than a general transfection effect. A non-targeting control helps separate sequence-specific effects from nonspecific treatment effects.
A reporter construct loses activity after mutation of a transcription-factor motif. The result suggests the motif
A is an intron that must be spliced
B encodes the reporter protein
C is a stop codon in the mRNA
D contributes to regulation in that assay
Answer: D. contributes to regulation in that assay. A motif mutation that lowers reporter activity supports a regulatory role in that assay.
If mRNA increases after a treatment but protein does not, one reasonable next measurement is
A translation efficiency or protein stability
B the cell’s chromosome count only
C the promoter’s DNA length only
D the amount of cellulose in the sample
Answer: A. translation efficiency or protein stability. Transcript abundance alone does not establish protein production; translation and turnover may differ.
For a valid gene-expression comparison, biological replicates are useful because they
A replace the need for controls
B capture natural variation among independent samples
C guarantee every transcript is identical
D remove all measurement error
Answer: B. capture natural variation among independent samples. Biological replicates estimate sample-to-sample variation and improve confidence in comparisons.
When comparing gene expression across tissues, a reference gene should be
A chosen only because it is highly expressed
B a gene known to change with the treatment
C validated as stable in those tissues and conditions
D identical to the target gene
Answer: C. validated as stable in those tissues and conditions. Reference genes should be empirically stable in the exact comparison.
A fluorescence reporter driven by a tissue-specific enhancer is detected only in that tissue. This most directly indicates
A that the reporter is the endogenous protein
B that every gene is active in that tissue
C that DNA replication occurs only there
D enhancer-dependent reporter expression in the tested model
Answer: D. enhancer-dependent reporter expression in the tested model. The signal reports activity of the enhancer–reporter construct in the tested model, not every feature of the native gene.